1.Advances in anticoagulant therapy for cirrhosis combined with atrial fibrillation.
Jie Ya REN ; Xin Ting LI ; Min Cong LONG ; Hui LIU ; Nu Er TANG ; Rong Jiong ZHENG ; Xiao Bo LU
Chinese Journal of Hepatology 2023;31(5):551-555
		                        		
		                        			
		                        			Relevant research in recent years has demonstrated that the atrial fibrillation occurrence rate is significantly higher in patients with cirrhosis. The most common indication for long-term anticoagulant therapy is chronic atrial fibrillation. The use of anticoagulant therapy greatly reduces the incidence rate of ischemic stroke. Patients with cirrhosis combined with atrial fibrillation have an elevated risk of bleeding and embolism during anticoagulant therapy due to cirrhotic coagulopathy. At the same time, the liver of such patients will go through varying levels of metabolism and elimination while consuming currently approved anticoagulant drugs, thereby increasing the complexity of anticoagulant therapy. This article summarizes the clinical studies on the risks and benefits of anticoagulant therapy in order to provide a reference for patients with cirrhosis combined with atrial fibrillation.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Atrial Fibrillation/epidemiology*
		                        			;
		                        		
		                        			Stroke/epidemiology*
		                        			;
		                        		
		                        			Anticoagulants/therapeutic use*
		                        			;
		                        		
		                        			Hemorrhage
		                        			;
		                        		
		                        			Liver Cirrhosis/drug therapy*
		                        			;
		                        		
		                        			Risk Factors
		                        			
		                        		
		                        	
2.Overview on the modern development of fire needling device: from tradition to innovation.
Yu-Qiang SONG ; Yuan-Bo FU ; Bin LI ; Jing-Qing SUN ; Hui-Lin LIU ; Ya-Li WEN ; Bing-Cong ZHAO ; Tian-Li LV ; Fan ZHANG ; Fang YUAN
Chinese Acupuncture & Moxibustion 2023;43(1):114-118
		                        		
		                        			
		                        			The appropriate needle device is crucial for obtaining the curative effect of fire needling therapy. The article introduces the material specification, clinical operation, indications, characteristics and advantages of the contemporary traditional fire needling devices (e.g. He's fire needle and Shi 's fire needle) and the contemporary new-type ones (e.g. fire needling with filiform needle and micro-needle); and determines the innovations of modern fire needling. It is anticipated that the needle specifications, production process and operation standard of fire needling devices should be further unified so as to provide the references for the selection of fire needling devices in treatment based on clinical syndrome differentiation and expand the clinical application of fire needling therapy.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Acupuncture Points
		                        			;
		                        		
		                        			Acupuncture Therapy
		                        			;
		                        		
		                        			Needles
		                        			
		                        		
		                        	
3.High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
Yi ZANG ; Mingbo SU ; Qingxing WANG ; Xi CHENG ; Wenru ZHANG ; Yao ZHAO ; Tong CHEN ; Yingyan JIANG ; Qiang SHEN ; Juan DU ; Qiuxiang TAN ; Peipei WANG ; Lixin GAO ; Zhenming JIN ; Mengmeng ZHANG ; Cong LI ; Ya ZHU ; Bo FENG ; Bixi TANG ; Han XIE ; Ming-Wei WANG ; Mingyue ZHENG ; Xiaoyan PAN ; Haitao YANG ; Yechun XU ; Beili WU ; Leike ZHANG ; Zihe RAO ; Xiuna YANG ; Hualiang JIANG ; Gengfu XIAO ; Qiang ZHAO ; Jia LI
Protein & Cell 2023;14(1):17-27
		                        		
		                        			
		                        			The global COVID-19 coronavirus pandemic has infected over 109 million people, leading to over 2 million deaths up to date and still lacking of effective drugs for patient treatment. Here, we screened about 1.8 million small molecules against the main protease (Mpro) and papain like protease (PLpro), two major proteases in severe acute respiratory syndrome-coronavirus 2 genome, and identified 1851Mpro inhibitors and 205 PLpro inhibitors with low nmol/l activity of the best hits. Among these inhibitors, eight small molecules showed dual inhibition effects on both Mpro and PLpro, exhibiting potential as better candidates for COVID-19 treatment. The best inhibitors of each protease were tested in antiviral assay, with over 40% of Mpro inhibitors and over 20% of PLpro inhibitors showing high potency in viral inhibition with low cytotoxicity. The X-ray crystal structure of SARS-CoV-2 Mpro in complex with its potent inhibitor 4a was determined at 1.8 Å resolution. Together with docking assays, our results provide a comprehensive resource for future research on anti-SARS-CoV-2 drug development.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Antiviral Agents/chemistry*
		                        			;
		                        		
		                        			COVID-19
		                        			;
		                        		
		                        			COVID-19 Drug Treatment
		                        			;
		                        		
		                        			High-Throughput Screening Assays
		                        			;
		                        		
		                        			Molecular Docking Simulation
		                        			;
		                        		
		                        			Protease Inhibitors/chemistry*
		                        			;
		                        		
		                        			SARS-CoV-2/enzymology*
		                        			;
		                        		
		                        			Viral Nonstructural Proteins
		                        			
		                        		
		                        	
4.Innovation, development and application of contemporary fire needling.
Yu-Qiang SONG ; Yuan-Bo FU ; Bin LI ; Jing-Qing SUN ; Hui-Lin LIU ; Ya-Li WEN ; Bing-Cong ZHAO ; Tian-Li LV ; Fan ZHANG ; Fang YUAN
Chinese Acupuncture & Moxibustion 2022;42(11):1317-1320
		                        		
		                        			
		                        			Physicians in the past dynasties have improved the theory of fire needling from the aspects of fire needling instruments, clinical efficacy, application scope, operation, precautions, etc., which promoted the clinical application of fire needling. Modern fire needling breaks through the traditional clinical taboos such as heat syndrome, face, forbidden acupoints, and no needle retention. By using modern fire needling with various types, characteristics and functions, multiple needles and multiple methods are used to treat various diseases, which can further exert the therapeutic effect of fire needling and promote the popularization and application of fire needle therapy.
		                        		
		                        		
		                        		
		                        			Acupuncture Therapy
		                        			;
		                        		
		                        			Acupuncture Points
		                        			;
		                        		
		                        			Vascular Surgical Procedures
		                        			;
		                        		
		                        			Needles
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
5.Status of Serum Uric Acid and Hyperuricemia among Adults in China: China Nutrition and Health Surveillance (2015).
Wei PIAO ; Ya Cong BO ; Li Yun ZHAO ; Dong Mei YU
Biomedical and Environmental Sciences 2022;35(10):911-920
		                        		
		                        			OBJECTIVE:
		                        			The purpose of this study was to determine the serum uric acid levels and the prevalence of hyperuricemia among Chinese adults in 2015 and compare the differences between urban and rural areas, as well as the differences between eastern, central, and western regions.
		                        		
		                        			METHODS:
		                        			A national representative sample of 180,208 participants were included using a stratified, multistage, and random sampling method. The demographic characteristics and blood samples were collected to determine the serum uric acid levels and prevalence of hyperuricemia among subgroups using complicated sampling weight. A t-test or ANOVA was used for normally-distributed data. The Kruskal-Wallis rank test was used for skewed-distributed data. The Mantel-Haenszel chi-square test was used to compare the difference in categorical variables.
		                        		
		                        			RESULTS:
		                        			The weighted mean uric acid level in Chinese adults was 310.4 μmol/L (317.5 μmol/L in urban areas and 302.9 μmol/L in rural areas). The weighted average values of uric acid in eastern, central, and western China were 315.5 μmol/L, 303.5 μmol/L, and 310.4 μmol/L, respectively. The weighted prevalence of hyperuricemia in Chinese adults was 14.6%, with a prevalence of 16.5% in urban areas and 12.5% in rural areas. The weighted prevalence of hyperuricemia in eastern, central, and western China was 16.0%, 12.5%, and 14.8%, respectively.
		                        		
		                        			CONCLUSION
		                        			The uric acid level in Chinese adults is relatively high. Effective actions are warranted to improve this metabolic abnormality.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hyperuricemia/epidemiology*
		                        			;
		                        		
		                        			Uric Acid
		                        			;
		                        		
		                        			Nutritional Status
		                        			;
		                        		
		                        			Asian People
		                        			;
		                        		
		                        			China/epidemiology*
		                        			
		                        		
		                        	
6.Effect of glucose metabolism disorders on the short-term prognosis in neonates with asphyxia: a multicenter study in Hubei Province, China.
Chun-Hua LIU ; Hui WANG ; Si-Cong PENG ; Wen-Xiang WANG ; Rong JIAO ; Sha PAN ; Tian-Jiao ZHU ; Xiao-Ying LUAN ; Xiao-Fang ZHU ; Su-Ying WU ; De-Guo WEI ; Bing-Feng FU ; Rui-Hong YAN ; Shu-Jie YANG ; Ya-Hui LUO ; Gui-Ping LI ; Min YANG ; De-Zhao JIA ; Chuang GAO ; Xiong-Fei XIAO ; Li XIONG ; Jie SUN ; Jia-Peng XIAO ; Bo-Wen LI ; Yan-Ni LI ; Lian-Hong ZHANG ; Tian-Guo LI ; Min CHENG ; Jian-Xin XIA ; Shi-Wen XIA
Chinese Journal of Contemporary Pediatrics 2021;23(12):1208-1213
		                        		
		                        			OBJECTIVES:
		                        			To study the effect of glucose metabolism disorders on the short-term prognosis in neonates with asphyxia.
		                        		
		                        			METHODS:
		                        			A retrospective analysis was performed on the medical data of the neonates with asphyxia who were admitted to 52 hospitals in Hubei Province of China from January to December, 2018 and had blood glucose data within 12 hours after birth. Their blood glucose data at 1, 2, 6, and 12 hours after birth (with an allowable time error of 0.5 hour) were recorded. According to the presence or absence of brain injury and/or death during hospitalization, the neonates were divided into a poor prognosis group with 693 neonates and a good prognosis group with 779 neonates. The two groups were compared in the incidence of glucose metabolism disorders within 12 hours after birth and short-term prognosis.
		                        		
		                        			RESULTS:
		                        			Compared with the good prognosis group, the poor prognosis group had a significantly higher proportion of neonates from secondary hospitals (48.5% vs 42.6%, 
		                        		
		                        			CONCLUSIONS
		                        			Recurrent hyperglycemia in neonates with asphyxia may suggest poor short-term prognosis, and it is necessary to strengthen the early monitoring and management of the nervous system in such neonates.
		                        		
		                        		
		                        		
		                        			Asphyxia
		                        			;
		                        		
		                        			Asphyxia Neonatorum/epidemiology*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hyperglycemia
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
7.Histopathological diagnosis and follow-up analysis of gastric mucosal biopsy
Yang-Kun WANG ; Bo JIANG ; Cong-Yang LI ; Jian CHEN ; Gong-Ping WANG ; Mei-Ling ZHU ; Bin-Feng YANG ; Chao-Ya ZHU ; Mei-Hua CHEN ; Qing-Qiu LI ; Lei CHEN
Chinese Journal of Clinical and Experimental Pathology 2018;34(2):137-142
		                        		
		                        			
		                        			Purpose To investigate the histopathological diagnosis and follow-up of gastric mucosal biopsy. Methods A detailed histopathological observation was performed on 5 748 gastroscopic biopsies and 3 288 patients were followed up. Results In 5 748 cases of endoscopy biopsy specimens, acute gastritis was rechecked in 125 cases, of which 112 cases were cured or improved (89.6% ), 10 cases (8.0% ) had little change, and 3 cases (2.4%) were aggravated. There were 2430 cases of chronic atrophic gastritis, in which 1521 cases were cured/improvement (62.6% ), 737 cases (30.3% ) had little change, and 172 cases (7.1% ) were aggravated. In the 71 cases of special type of gastritis, 23 cases were cured or improved, accounting for 32.3%.42 cases were not changed much, accounting for 59.2%, and 6 cases were aggravated (8.5% ). About druginduced gastritis/stomach reexamination in 94 cases, 57 cases were cured/improved, accounting for 60.6%, 34(36.3% ) cases did not change, and 2 cases were aggravated(3.2% ).183 cases of gastric polyp were reviewed, 165 cases(90.2% ) were cured / improved, 13 cases (7.1% ) were not changed and 5 cases (2.7% ) were aggravated. No neoplasia/ nondysplasia was found in 205 cases, 196(95.6% ) cases was cured / improved, no change was seen in 6 cases (2.9% ) and aggravation was seen in 3 cases(1.5%). Indefinite neoplasia/ dysplasia was reexamined in 24 cases, 2 cases (8.3%) were cured/improved, no change was seen in 13 cases (54.2% ), and aggravation was seen in 9 cases(37.5%).156 cases of intraepithelial neoplasia were retrospectively reviewed, in which138 (88.5% ) cases were cured or improved, 4(2.6% ) cases showed no change, and 13(8.3%) cases were aggravated. Conclusion It is of great significance to improve the early diagnosis rate, reduce missed diagnosis rate and misdiagnosis rate of gastric cancer by establishing 11 pathological changes and accompanying lesions.
		                        		
		                        		
		                        		
		                        	
8.Construction of a stable 4.1R gene knockout cell model in RAW264.7 cells using CRISPR/Cas9 technique.
Cheng-Bo WANG ; Qiao-Zhen KANG ; Cong DING ; Ya-Wen LI ; Tao-Tao LIANG ; Cheng-Long ZHANG ; Wen WANG ; Ting WANG
Journal of Southern Medical University 2017;37(12):1609-1614
OBJECTIVETo construct a cell model of 4.1R gene knockout in murine macrophage cell line RAW264.7 using CRISPR/Cas9 technique.
METHODSThree high?grade small?guide RNAs (sgRNAs) that could specifically identify 4.1R gene were synthesized and inserted into lentiCRISPRv2 plasmid. RAW264.7 cells were infected with sgRNA?Cas9 lentivirus from 293T cells transfected with the recombinant sgRNA?lentiCRISPRv2 plasmid, and the positive cells were screened using puromycin and the monoclonal cells were obtained. The expression of 4.1R protein in the monoclonal cells was measured by Western blotting, and the mutation site was confirmed by sequence analysis. Result A 4.1R gene knockout RAW264.7 cell line was obtained, which showed a 19?bp deletion mutation in the 4.1R gene sequence and obviously enhanced proliferation.
CONCLUSIONWe successfully constructed a 4.1R gene knockout macrophage cell line using CRISPR/Cas9 technique, which may facilitate further investigation of the function of 4.1R in macrophages.
9.Protective effects of Liuwei Wuling tablet on acute alcoholic-induced liver injury in mice.
Ping YIN ; He-Rong CUI ; Cong-En ZHANG ; Yuan ZHANG ; Ya-Kun MENG ; Lan-Zhi HE ; Hui-Min LIU ; Xiu-Xiu SANG ; Jia-Bo WANG ; Zhao-Fang BAI ; Xiao-He XIAO
China Journal of Chinese Materia Medica 2016;41(19):3637-3642
		                        		
		                        			
		                        			The protective action and the relevant mechanism of Liuwei Wuling tablet on acute alcoholic hepatic injury in mice were investigated. All the C57BL/6 mice were divided randomly into 7 groups including blank, model, bifendate (150 mg•kg⁻¹, positive control) and experimental groups consisted of extremely low dose (0.1 g•kg⁻¹), low (0.5 g•kg⁻¹), upper (4 g•kg⁻¹) and high dose (8 g•kg⁻¹) of Liuwei Wuling tablet groups. The acute liver injury model was induced by modified method that the model, positive control and experimental groups were orally administrated 56% alcohol (6 g•kg⁻¹) twice at 12 hour intervals on the fifth day after drugs administration. After 12 hours, the mice were sacrificed to contribute blood and liver for biochemical and histological examinations. Compared with the model, the activities of ALT and AST in serum decreased significantly in different Liuwei Wuling tablet groups. Meanwhile, in liver tissue, the levels of TG, MDA, TNF-α and IL-1β reduced obviously while the GSH and SOD activities showed markedly increase with a dose-dependent manner. Correspondingly, the microscopically pathological differences of the liver tissue observed by HE and oil red O staining indicated that the liver cell swelling, hydropic degeneration and lipid droplets formation induced by alcohol were significantly improved, which suggested the Liuwei Wuling tablet can reduce the liver injure. In conclusion, the Liuwei Wuling tablet had the protective effect on acute alcoholic hepatic injury which maybe depended on the mechanism of relieving lipid peroxidation, elevating antioxidant enzymes activity, inhibiting oxidative stress and reducing inflammation factors expression.
		                        		
		                        		
		                        		
		                        	
10.Relationship between coronal intercondylar notch width index and osteoarthritis.
Cong CHEN ; Yin-Hua MA ; Xiao-Yi TAN ; Bo ZHANG ; Bin GENG ; Jin JIANG ; Meng WU ; Ya-Yi XIA
Journal of Southern Medical University 2015;35(10):1384-1389
OBJECTIVETo study the relationship between knee osteoarthritis (OA) and intercondylar notch narrowing based on the notch width index.
METHODSMagnetic resonance (MR) images were collected from middle-aged and elderly patients with a definite diagnosis of knee OA, including 42 with mild OA and 37 with moderate to severe OA, with 70 healthy individuals serving as the control group. The notch width indexes NWI, NWI-A, and NWI-P on the coronal images at different levels were calculated, and the intercondylar notch was classified, according to the features on axial MR images, into types A, U, and W. The association of OA with NWI, NWI-A, NWI-P, and notch type was determined, and the cutoff values were obtained based on the ROC curves at different levels as indicators for diagnosis of intercondylar notch stenosis.
RESULTSIn the control, mild OA, moderate to severe OA groups, the NWI value on coronal MR images were 0.252±0.019, 0.251±0.017, and 0.240±0.020, NWI-A were 0.261±0.024, 0.259±0.023, and 0.245±0.023, and NWI-P were 0.271±0.026, 0.270±0.024, and 0.254±0.022, respectively. Patients with moderate to severe OA had significantly smaller NWI, NWI-A, and NWI-P than the other two groups (P<0.05), and a significant association was found between NWI values at each level and the occurrence of moderate to severe OA (P<0.01). A NWI value<0.248, NWI-A<0.256, and NWI-P<0.266 supported a diagnosis of intercondylar notch narrowing. Type A intercondylar notch was found in the majority of patients with intercondylar notch narrowing (P<0.05).
CONCLUSIONPatients with moderate to severe OA have significant intercondylar notch narrowing, and patients with a type A intercondylar notch are more likely to have intercondylar notch narrowing than those with type U notch.
Aged ; Case-Control Studies ; Constriction, Pathologic ; Humans ; Knee Joint ; anatomy & histology ; Magnetic Resonance Imaging ; Middle Aged ; Osteoarthritis, Knee ; pathology ; ROC Curve
            
Result Analysis
Print
Save
E-mail